FI922124A0 - Azabicykloamider och -estrar som 5-ht3-receptorantagonister. - Google Patents

Azabicykloamider och -estrar som 5-ht3-receptorantagonister.

Info

Publication number
FI922124A0
FI922124A0 FI922124A FI922124A FI922124A0 FI 922124 A0 FI922124 A0 FI 922124A0 FI 922124 A FI922124 A FI 922124A FI 922124 A FI922124 A FI 922124A FI 922124 A0 FI922124 A0 FI 922124A0
Authority
FI
Finland
Prior art keywords
receptorantagonister
azabicycloamider
estrar
som
och
Prior art date
Application number
FI922124A
Other languages
English (en)
Other versions
FI922124A (fi
Inventor
Terry J Rosen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI922124A0 publication Critical patent/FI922124A0/fi
Publication of FI922124A publication Critical patent/FI922124A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI922124A 1989-11-17 1992-05-11 Azabicykloamider och -estrar som 5-ht3-receptorantagonister. FI922124A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005097 WO1991007402A1 (en) 1989-11-17 1989-11-17 Azabicyclo amides and esters as 5-ht3 receptor antagonists

Publications (2)

Publication Number Publication Date
FI922124A0 true FI922124A0 (fi) 1992-05-11
FI922124A FI922124A (fi) 1992-05-11

Family

ID=22215354

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922124A FI922124A (fi) 1989-11-17 1992-05-11 Azabicykloamider och -estrar som 5-ht3-receptorantagonister.

Country Status (11)

Country Link
EP (1) EP0434202B1 (fi)
JP (1) JPH0699428B2 (fi)
AT (1) ATE106886T1 (fi)
CA (1) CA2030077C (fi)
DE (1) DE69009715T2 (fi)
DK (1) DK0434202T3 (fi)
ES (1) ES2055344T3 (fi)
FI (1) FI922124A (fi)
IE (1) IE63420B1 (fi)
PT (1) PT95895A (fi)
WO (1) WO1991007402A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027111D0 (en) * 1990-12-13 1991-02-06 Raychem Ltd Circuit protection device
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
DE602005019094D1 (de) * 2004-12-22 2010-03-11 Memory Pharmaceutical Corp Nikotinische alpha-7-rezeptorliganden gegen erkrankungen des zns

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3405134A (en) * 1965-08-17 1968-10-08 Colgate Palmolive Co Quinuclidyl esters of aromatic acids
US4467095A (en) * 1969-02-10 1984-08-21 Fmc Corporation Anticholinergic compounds
US3563995A (en) * 1969-04-17 1971-02-16 Ian Wellings Alkyl esters of 1-azabicyclo(2.2.2)oct-2-ene-3-(4 - chloro-3-sulfamoylanilino)-2-carboxylic acid
GB1293446A (en) * 1970-07-23 1972-10-18 Rech S Et D Applic Scient Soge Quinuclidine derivatives, the preparation thereof and pharmaceutical compositions containing them
FR2531955A1 (fr) * 1982-08-17 1984-02-24 Pharmuka Lab Nouveau procede de preparation de derives de la quinuclidine substitues en position 3
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
EP0311724A1 (en) * 1987-10-16 1989-04-19 Synthelabo Anxiolytic-R-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides

Also Published As

Publication number Publication date
EP0434202A1 (en) 1991-06-26
JPH0699428B2 (ja) 1994-12-07
DE69009715T2 (de) 1994-09-22
DE69009715D1 (de) 1994-07-14
CA2030077C (en) 1995-08-22
ES2055344T3 (es) 1994-08-16
DK0434202T3 (da) 1994-07-04
JPH03170480A (ja) 1991-07-24
WO1991007402A1 (en) 1991-05-30
PT95895A (pt) 1991-09-13
IE904134A1 (en) 1991-05-22
FI922124A (fi) 1992-05-11
ATE106886T1 (de) 1994-06-15
EP0434202B1 (en) 1994-06-08
IE63420B1 (en) 1995-04-19
CA2030077A1 (en) 1991-05-18

Similar Documents

Publication Publication Date Title
SE8303651L (sv) Bensoesyrapiperidylesterderivat
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
DE3476204D1 (de) N-(bicyclic heterocyclyl)-4-piperidinamines
FI921345A0 (fi) Piperidinderivat.
DE69207351D1 (de) Fibrinogen-Rezeptor-Antagoniste
ES2096560T3 (es) Compuestos de benzocicloheptapiridina sustituida con fluor, composiciones y metodos para uso como compuestos antihistaminicos.
DK0804196T3 (da) Anvendelse af serotoninantagonister (5HT 3) til behandling af fibromyalgia
MX9101311A (es) Antagonistas receptores de fibrinogeno
EP0698023A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
DE69008741D1 (de) Mehrachsiger Roboter.
DE69116705D1 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
ATE198202T1 (de) Fibrinogen receptor antagonisten
FR2625678B1 (fr) Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
DK0434202T3 (da) Azabicycloamider og -estere som 5-HT3-receptor-antagonister
FI891473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
ATE181257T1 (de) Testbesteck
FI913835A (fi) 6-substituerade-tetrahydrobenz(cd) indoler.
DE69328701D1 (de) Diazabicycloderivate als 5-HT3-Antagonisten
DE59400032D1 (de) Vorrichtung zum Dämpfen von Bewegungen.
DE69031789D1 (de) Räumliche Scheitelerhöhung für den Übergang von Detailniveaus
ATE40130T1 (de) N-(bizyklische heterozyklyl)-4-piperidinamine.
IT9083326A0 (it) Attrezzo per sviluppare le capacita' psico-motorie del bambino
LV10425A (lv) Fibrinogena receptoru antagonisti
RO86811A2 (ro) Compozitie vulcanizabila pe baza de cauciuc de uz general
DK278390D0 (da) Ryglaen til arbejdsstol

Legal Events

Date Code Title Description
FD Application lapsed